We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Water Soluble Ball Delivers Accurate Quantitative Microbiological Control

By LabMedica International staff writers
Posted on 04 Jan 2011
Print article
Image: The bioMérieux BioBall (photo courtesy bioMérieux).
Image: The bioMérieux BioBall (photo courtesy bioMérieux).
A small, water-soluble ball containing a precise number of microorganisms, delivers unprecedented accuracy for quantitative microbiological quality control.

Dubbed BioBall, the standard ball products are derived from strains sourced from internationally recognized culture collections.

bioMérieux, (Marcy l'Etoile, France), a leader in the field of in vitro diagnostics (IVD) and in microbiological control for the biopharma and food industries, developed BioBall to provide pharmaceutic microbiology laboratories with their own isolates in a convenient, easy-to-use format.

Many pharmaceutic companies implement standard operating procedures that incorporate several representative strains from among their own bacterial and fungal isolates (from environmental monitoring, sterility, or bioburden testing). Maintaining these strains in-house is time-consuming and costly compared with the quality control (QC) strains such as BioBall that are available for routine use.

BTF (Sydney, Australia), a bioMérieux company, developed the BioBall Plant Isolate service in response to changing practices in culture media quality control for validation and routine testing. BioBall Plant Isolate will enable customers to implement best practices in media QC for their critical environmental monitoring and sterility testing.

BioBall mixed kits contain the most relevant pharmacopeia strains required for quantitative microbiology. Three different products for pharmaceutic QC are available: BioBall SingleShot, BioBall MultiShot 550, and BioBall MultiShot 10E8

BioBall SingleShot mixed kit and BioBall MultiShot 550 mixed kit contain two vials of Aspergillus brasiliensis, two vials of Bacillus subtilis, one vial of Candida albicans, one vial of Escherichia coli, two vials of Pseudomonas aeruginosa, and two vials of Staphylococcus aureus.

BioBall MultiShot 10E8 contains the same mixture of bacteria without C. albicans.

Related Links:

bioMérieux
BTF


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.